Multidrug Regimen in Paucibacillary Leprosy For Six and Twelve Months (A Comapritive Study)
|How to cite this article:
Kar P K, Jha P K, Snehi P S, Sohi A S. Multidrug Regimen in Paucibacillary Leprosy For Six and Twelve Months (A Comapritive Study). Indian J Dermatol Venereol Leprol 1989;55:308-309
AbstractEfficacy of multidrug therapy (MDT) for paucibacillary leprosy for 12 months was evaluated in 91 fresh cases, which included indeterminate (28 cases), tuberculoid (22) and borderline tuberculoid leprosy (41 cases). All were males and were hospitawd. The MDT consisted of rifampicin 600 mg once a month and dapsone 100 mg daily. Both drugs were given concomitantly for 12 months. At the end of 6 months, 37.2% cases remained clinically active. At the end of once year, 91.2% cases receiving MDT became inactive.